Priority Date: 30.03.11 (KR 20110028603)

NOVEL CEPHALOSPORIN DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF

  • Application ID: EP12765589
  • Status: GRANT OF PATENT INTENDED

Attorneys

operating since 1937
Headquarter in Wiesbaden, Berlin and 1 office
active in Legal Services
no operation time available
4 offices
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Fuchs Patentanwälte Partnerschaft mbB and AstraZeneca PLC are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 225 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 30.03.2011 - Priority Date (KR 20110028603)
  • 04.10.2012 - Publication A2 (WO2012134184)
  • 12.03.2014 - Publication A2 (EP2706062)